Pyxis Oncology, Inc. (PYXS) operating KPIs

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$1.81−0.08 (-4.23%)

Close on Oct 30, 2026Market cap $150.97MP/E –Yield –

KPIs

Operating metrics that drive Pyxis Oncology's business

Rentable area (sq ft)	Q2 26	Q1 26	Q3 25	Q2 25	Q1 25	YoY
Rentable area	17,729	17,729	17,729	17,729	17,729	0.0%

Counts and sizes Pyxis Oncology tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.